1Jelovac, A, Kolshus, E, McLoughlin, DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology 2013; 38: 2467–74.
2Sackeim, HA, Haskett, RF, Mulsant, BH, Thase, ME, Mann, JJ, Pettinati, HM, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001; 285: 1299–307.
3UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799–808.
4Hermida, AP, Glass, OM, Shafi, H, McDonald, WM. Electroconvulsive therapy in depression: current practice and future direction. Psychiatr Clin North Am 2018; 41: 341–53.
5Cipriani, A, Hawton, K, Stockton, S, Geddes, JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013; 346: f3646.
6Sackeim, HA, Prudic, J, Devanand, DP, Decina, P, Kerr, B, Malitz, S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990; 10: 96–104.
7Prudic, J, Haskett, RF, McCall, WV, Isenberg, K, Cooper, T, Rosenquist, PB, et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT 2013; 29: 3–12.
8Rosen, BH, Kung, S, Lapid, MI. Effect of age on psychiatric rehospitalization rates after electroconvulsive therapy for patients with depression. J ECT 2016; 32: 93–8.
9Nordenskjold, A, von Knorring, L, Engstrom, I. Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study. Depress Res Treat 2011; 2011: 470985.
10Kellner, CH, Knapp, RG, Petrides, G, Rummans, TA, Husain, MM, Rasmussen, K, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63: 1337–44.
11Rasmussen, KG. Lithium for post-electroconvulsive therapy depressive relapse prevention: a consideration of the evidence. J ECT 2015; 31: 87–90.
12Geddes, JR, Burgess, S, Hawton, K, Jamison, K, Goodwin, GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217–22.
13Bauer, M, Adli, M, Ricken, R, Severus, E, Pilhatsch, M. Role of lithium augmentation in the management of major depressive disorder. CNS Drugs 2014; 28: 331–42.
14Coppen, A, Abou-Saleh, MT, Milln, P, Bailey, J, Metcalfe, M, Burns, BH, et al. Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 1981; 139: 284–7.
15Perry, P, Tsuang, MT. Treatment of unipolar depression following electroconvulsive therapy. Relapse rate comparisons between lithium and tricyclics therapies following ECT. J Affect Disord 1979; 1: 123–9.
16Shapira, B, Gorfine, M, Lerer, B. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convuls Ther 1995; 11: 80–5.
17Atiku, L, Gorst-Unsworth, C, Khan, BU, Huq, F, Gordon, J. Improving relapse prevention after successful electroconvulsive therapy for patients with severe depression: completed audit cycle involving 102 full electroconvulsive therapy courses in West Sussex, United Kingdom. J ECT 2015; 31: 34–6.
18Socialstyrelsen. Internationell Klassifikation av Sjukdomar och Relaterade Hälsoproblem - SYSTEMATISK FÖRTECKNING, SVENSK VERSION 2011 (ICD-10-SE). [International Classification of Diseases and Related Health Problems - SYSTEMATIC LIST, SWEDISH VERSION 2011 (ICD-10-SE).] Socialstyrelsen, 2010.
19Ludvigsson, JF, Andersson, E, Ekbom, A, Feychting, M, Kim, JL, Reuterwall, C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
22Oquendo, MA, Baca-Garcia, E, Kartachov, A, Khait, V, Campbell, CE, Richards, M, et al. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry 2003; 64: 825–33.
24Brooke, HL, Talback, M, Hornblad, J, Johansson, LA, Ludvigsson, JF, Druid, H, et al. The Swedish cause of death register. Eur J Epidemiol 2017; 32: 765–73.
25Nordanskog, P, Hulten, M, Landen, M, Lundberg, J, von Knorring, L, Nordenskjold, A. Electroconvulsive therapy in Sweden 2013: data from the national quality register for ECT. J ECT 2015; 31: 263–7.
26Guy, W. ECDEU Assessment Manual for Psychopharmacology. . National Institute for Mental Health, 1976.
27Socialstyrelsen. Nationella Riktlinjer För Vård vid Depression Och Ångestsyndrom - Stöd för Styrning och Ledning. [National guidelines for care of depression and anxiety syndromes – Steering and Leading.] Socialstyrelsen, 2017.
28Nordenskjold, A, von Knorring, L, Ljung, T, Carlborg, A, Brus, O, Engstrom, I. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial. J ECT 2013; 29: 86–92.
29Kellner, CH, Husain, MM, Knapp, RG, McCall, WV, Petrides, G, Rudorfer, MV, et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am J Psychiatry 2016; 173: 1110–8.
30Nicholson, MW, Sweeney, A, Pekle, E, Alam, S, Ali, AB, Duchen, M, et al. Diazepam-induced loss of inhibitory synapses mediated by PLCdelta/ Ca(2+)/calcineurin signalling downstream of GABAA receptors. Mol Psychiatry 2018; 23: 1851–67.
31Maya Vetencourt, JF, Sale, A, Viegi, A, Baroncelli, L, De Pasquale, R, O'Leary, OF, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008; 320: 385–8.
32Brus, O, Cao, Y, Gustafsson, E, Hulten, M, Landen, M, Lundberg, J, et al. Self-assessed remission rates after electroconvulsive therapy of depressive disorders. Eur Psychiatry 2017; 45: 154–60.
33Petrides, G, Fink, M, Husain, MM, Knapp, RG, Rush, AJ, Mueller, M, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17: 244–53.
34Munk-Olsen, T, Laursen, TM, Videbech, P, Mortensen, PB, Rosenberg, R. All-cause mortality among recipients of electroconvulsive therapy: register-based cohort study. Br J Psychiatry 2007; 190: 435–9.